Limbix: Funding, Investors & Team (Oct 2026)
Limbix is a prescription digital therapeutic company passionate about creating mental health treatments for adolescents. The Limbix team is uniquely suited to develop prescription digital therapeutics, as its diverse team of clinicians, product designers, researchers, and engineers understand the value of pairing clinical expertise with technological innovation. Their first digital therapeutic, SparkRx by Limbix, is available for licensed healthcare professionals to offer to patients nationwide. For more information about Limbix and SparkRx, please visit limbix.com and SparkRx.com.
Limbix has raised $24.0M across 2 funding rounds on record, the most recent a Series A of $15.0M announced in Dec 2021.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Limbix Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Limbix Funding Rounds
Limbix raised $9.0M in an undisclosed round announced in May 2020.
1.6 years later, a Series A of $15.0M was announced in Dec 2021.
Limbix Founders and Leadership Team
Contact details for the Limbix team: 1 of 1 has an email address on file.
Start 14-day free trial →Limbix Funding Compared to Other Biotechnology Startups
Limbix's latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Limbix in Biotechnology and Palo Alto
Companies Similar to Limbix
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Limbix Funding FAQs
What does Limbix do?
Limbix is a prescription digital therapeutic company passionate about creating mental health treatments for adolescents. The Limbix team is uniquely suited to develop prescription digital therapeutics, as its diverse team of clinicians, product designers, researchers, and engineers understand the value of pairing clinical expertise with technological innovation. Their first digital therapeutic, SparkRx by Limbix, is available for licensed healthcare professionals to offer to patients nationwide. For more information about Limbix and SparkRx, please visit limbix.com and SparkRx.com.
How much funding has Limbix raised?
Limbix has raised $24.0M across 2 rounds on record. The most recent is a Series A of $15.0M announced in Dec 2021.
When did Limbix last raise funding?
Limbix's most recent funding round on record is a Series A of $15.0M, announced in Dec 2021.
Who is the CEO of Limbix?
Ben Lewis is listed as CEO at Limbix.
Where is Limbix headquartered?
Limbix is based in Palo Alto, California, United States.
How many employees does Limbix have?
Limbix is in the 11-50 employee band.
How does Limbix's funding compare to other Biotechnology startups?
Limbix's latest round of $15.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Limbix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Limbix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.